Akebia Therapeutics (AKBA)

Add to Watchlists
Create an Alert
7.52 +0.05  +0.67% NASDAQ Sep 2, 17:00 Delayed 2m USD
View Full Chart
AKBA Price Chart
View All Performance Charts

AKBA Total Returns Comparison

Advertisement

AKBA Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.akebia.com
  • IR Website: http://ir.akebia.com/
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: September 30, 2014
  • Last Fiscal Year End: N/A
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Akebia Therapeutics Inc is a biopharmaceutical company. It is engaged in the development of proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease.

AKBA Excel Add-In Codes

  • Name: =YCI("AKBA","name")
  • Description: =YCI("AKBA","description")
  • Sector: =YCI("AKBA","sector")
  • Industry: =YCI("AKBA","industry")
  • Est. Current Fiscal Year End: =YCI("AKBA","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.